Cargando…

Prediction Model and Risk Stratification Tool for Survival in Patients With CKD

INTRODUCTION: Because chronic kidney disease (CKD) adversely affects survival, prediction of mortality risk should help to identify individuals requiring therapeutic intervention. The goal of this project was to construct and to validate a risk scoring system and prediction model of the probability...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldfarb-Rumyantzev, Alexander S., Gautam, Shiva, Dong, Ning, Brown, Robert S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932311/
https://www.ncbi.nlm.nih.gov/pubmed/29725646
http://dx.doi.org/10.1016/j.ekir.2017.11.010
_version_ 1783319785706094592
author Goldfarb-Rumyantzev, Alexander S.
Gautam, Shiva
Dong, Ning
Brown, Robert S.
author_facet Goldfarb-Rumyantzev, Alexander S.
Gautam, Shiva
Dong, Ning
Brown, Robert S.
author_sort Goldfarb-Rumyantzev, Alexander S.
collection PubMed
description INTRODUCTION: Because chronic kidney disease (CKD) adversely affects survival, prediction of mortality risk should help to identify individuals requiring therapeutic intervention. The goal of this project was to construct and to validate a risk scoring system and prediction model of the probability of 2-year mortality in a CKD population. METHODS: We applied the Woodpecker approach to develop prediction equations using linear, exponential, and combined models. A risk indicator R on a scale of 0 to 10 was calculated as follows: starting with 0, add 0.048 for each year of age above 20, 0.45 for male sex, 0.49 for each stage of CKD over stage 2, 1.04 for proteinuria, 0.72 for smoking history, and 0.49 for each significant comorbidity up to 5. RESULTS: Using R to predict 2-year mortality, the model yielded an area under the receiver operating characterisic curve of 0.83 (95% confidence interval = 0.81−0.86) with 5062 subjects with CKD ≥stage 2 from a National Health and Nutrition Examination Survey cohort (1999−2004) having a 3.2% 2-year mortality. The combined expression offered results closest to most actual outcomes for the entire population and for each CKD stage. For those patients with higher risk (R ≥ 4−5, >5−6, and >6), the predicted 2-year mortality rates were 3.8%, 6.4%, and 13.0%, respectively, compared to observed mortality rates of 2.7%, 4.5%, and 13.3%. CONCLUSION: The risk stratification tool and prediction model of 2-year mortality demonstrated good performance and may be used in clinical practice to quantify the risk of death for individual patients with CKD.
format Online
Article
Text
id pubmed-5932311
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-59323112018-05-03 Prediction Model and Risk Stratification Tool for Survival in Patients With CKD Goldfarb-Rumyantzev, Alexander S. Gautam, Shiva Dong, Ning Brown, Robert S. Kidney Int Rep Clinical Research INTRODUCTION: Because chronic kidney disease (CKD) adversely affects survival, prediction of mortality risk should help to identify individuals requiring therapeutic intervention. The goal of this project was to construct and to validate a risk scoring system and prediction model of the probability of 2-year mortality in a CKD population. METHODS: We applied the Woodpecker approach to develop prediction equations using linear, exponential, and combined models. A risk indicator R on a scale of 0 to 10 was calculated as follows: starting with 0, add 0.048 for each year of age above 20, 0.45 for male sex, 0.49 for each stage of CKD over stage 2, 1.04 for proteinuria, 0.72 for smoking history, and 0.49 for each significant comorbidity up to 5. RESULTS: Using R to predict 2-year mortality, the model yielded an area under the receiver operating characterisic curve of 0.83 (95% confidence interval = 0.81−0.86) with 5062 subjects with CKD ≥stage 2 from a National Health and Nutrition Examination Survey cohort (1999−2004) having a 3.2% 2-year mortality. The combined expression offered results closest to most actual outcomes for the entire population and for each CKD stage. For those patients with higher risk (R ≥ 4−5, >5−6, and >6), the predicted 2-year mortality rates were 3.8%, 6.4%, and 13.0%, respectively, compared to observed mortality rates of 2.7%, 4.5%, and 13.3%. CONCLUSION: The risk stratification tool and prediction model of 2-year mortality demonstrated good performance and may be used in clinical practice to quantify the risk of death for individual patients with CKD. Elsevier 2017-11-28 /pmc/articles/PMC5932311/ /pubmed/29725646 http://dx.doi.org/10.1016/j.ekir.2017.11.010 Text en © 2017 International Society of Nephrology. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Clinical Research
Goldfarb-Rumyantzev, Alexander S.
Gautam, Shiva
Dong, Ning
Brown, Robert S.
Prediction Model and Risk Stratification Tool for Survival in Patients With CKD
title Prediction Model and Risk Stratification Tool for Survival in Patients With CKD
title_full Prediction Model and Risk Stratification Tool for Survival in Patients With CKD
title_fullStr Prediction Model and Risk Stratification Tool for Survival in Patients With CKD
title_full_unstemmed Prediction Model and Risk Stratification Tool for Survival in Patients With CKD
title_short Prediction Model and Risk Stratification Tool for Survival in Patients With CKD
title_sort prediction model and risk stratification tool for survival in patients with ckd
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932311/
https://www.ncbi.nlm.nih.gov/pubmed/29725646
http://dx.doi.org/10.1016/j.ekir.2017.11.010
work_keys_str_mv AT goldfarbrumyantzevalexanders predictionmodelandriskstratificationtoolforsurvivalinpatientswithckd
AT gautamshiva predictionmodelandriskstratificationtoolforsurvivalinpatientswithckd
AT dongning predictionmodelandriskstratificationtoolforsurvivalinpatientswithckd
AT brownroberts predictionmodelandriskstratificationtoolforsurvivalinpatientswithckd